Careers  |  Sign In  |  Register  |   Twitter

Careful Processing & Purification of Placental Tissue Yields Superior Human Amniotic Membrane Allografts

Charles M. Zelen, DPM, FACFAS, discusses some of the challenges of producing EpiFix, a leading dehydrated Human Amnion/Chorion Membrane (dHACM) allograft. MiMedx, the creator of EpiFix, has developed the proprietary PURION® Process, which preserves the advantageous healing properties of the placental tissue while protecting its delicate structure. The EpiFix product has proven extremely effective at healing diabetic foot wounds, venous leg wounds, as well as many other skin lacerations.

None of this would be possible, however, without the generous donations of placentas from new mothers. MiMedx has created a program that makes it easy for women to donate their placentas after a Caesarean section while giving them the peace of mind that this generous donation has two key beneficiaries: (1) patients whom receive treatment with the EpiFix products, and (2) disadvantaged patients across the country whom receive life-changing surgeries made possible by MiMedx’s Healing Gifts program.

Charles M. Zelen, DPM, FACFAS
Contracted Research: MiMedx